Monashee Investment Management LLC Tyme Technologies, Inc. Transaction History

Monashee Investment Management LLC

  • $704 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 13, 2018
SELL
$2.18 - $3.44 $43,600 - $68,800
-20,000 Closed
0 $0
Q2 2018

Aug 10, 2018
SELL
$2.05 - $4.09 $553,500 - $1.1 Million
-270,000 Reduced 93.1%
20,000 $63,000
Q1 2018

May 10, 2018
BUY
$2.12 - $7.0 $572,400 - $1.89 Million
270,000 Added 1350.0%
290,000 $647,000
Q4 2017

Feb 09, 2018
BUY
$3.25 - $7.3 $65,000 - $146,000
20,000
20,000 $128,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email